Delivery Order SPE2DX22D0129-SPE2D826F0BTR
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $46,475.04 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 29, 2025, with a completion deadline of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,634.88 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,674.78 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded and reflects the company's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $174,350.56 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price delivery order, issued without set-aside provisions, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $79,064.32 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, which was not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,167.54 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the company's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $20,895.86 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order was performed...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $4,977.12 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, which is not a set-aside contract, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $17,005.64 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,473.56 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the prime contractor's Corporate Office located in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0BTRDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,167.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive portfolio of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive federal contract history with DLA demonstrates its capability to meet competitive procurement requirements and support military healthcare programs worldwide. This delivery order continues AmerisourceBergen's role as a primary vendor within the Medical Supply Chain, supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 11/30/25 |